Published in Pharm Res on October 01, 1992
Transformation of malaria parasites by the spontaneous uptake and expression of DNA from human erythrocytes. Nucleic Acids Res (2001) 3.06
Mechanism of oligonucleotide release from cationic liposomes. Proc Natl Acad Sci U S A (1996) 2.19
DNA-based therapeutics and DNA delivery systems: a comprehensive review. AAPS J (2005) 2.03
Cyclic amphipathic peptide-DNA complexes mediate high-efficiency transfection of adherent mammalian cells. Proc Natl Acad Sci U S A (1993) 1.65
Physicochemical characterization and purification of cationic lipoplexes. Biophys J (1999) 1.31
Phosphorothioate oligodeoxyribonucleotides dissociate from cationic lipids before entering the nucleus. Nucleic Acids Res (1998) 1.22
Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens. Vaccine (2012) 1.21
Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems. J Pharm Sci (2013) 1.16
Polymeric micelles for delivery of poorly soluble drugs: preparation and anticancer activity in vitro of paclitaxel incorporated into mixed micelles based on poly(ethylene glycol)-lipid conjugate and positively charged lipids. J Drug Target (2005) 1.12
Tunable pH-sensitive liposomes composed of mixtures of cationic and anionic lipids. Biophys J (2000) 1.11
Systemic gene therapy: biodistribution and long-term expression of a transgene in mice. Proc Natl Acad Sci U S A (1995) 1.07
Branched co-polymers of histidine and lysine are efficient carriers of plasmids. Nucleic Acids Res (2001) 1.04
Functional lipids and lipoplexes for improved gene delivery. Biochimie (2011) 0.96
Carrier-based strategies for targeting protein and peptide drugs to the lungs. AAPS J (2005) 0.96
Liposomal lipopolysaccharide initiates TRIF-dependent signaling pathway independent of CD14. PLoS One (2013) 0.96
pHLIP®-mediated delivery of PEGylated liposomes to cancer cells. J Control Release (2013) 0.95
Intracellular trafficking of polyamidoamine-poly(ethylene glycol) block copolymers in DNA delivery. Bioconjug Chem (2011) 0.92
A physicochemical approach for predicting the effectiveness of peptide-based gene delivery systems for use in plasmid-based gene therapy. Biophys J (1998) 0.91
A new helper phospholipid for gene delivery. Chem Commun (Camb) (2008) 0.87
Natural lipid extracts and biomembrane-mimicking lipid compositions are disposed to form nonlamellar phases, and they release DNA from lipoplexes most efficiently. Biochim Biophys Acta (2007) 0.85
Liposome/DNA complexes coated with biodegradable PLA improve immune responses to plasmid encoding hepatitis B surface antigen. Immunology (2002) 0.84
Cationic nucleoside lipids based on a 3-nitropyrrole universal base for siRNA delivery. Bioconjug Chem (2009) 0.84
Synthesis, characterization, and in vitro transfection activity of charge-reversal amphiphiles for DNA delivery. Bioconjug Chem (2011) 0.84
Complexes containing cationic and anionic pH-sensitive liposomes: comparative study of factors influencing plasmid DNA gene delivery to tumors. Int J Nanomedicine (2013) 0.79
Bone marrow-targeted liposomal carriers. Expert Opin Drug Deliv (2011) 0.79
pH-Sensitive stimulus-responsive nanocarriers for targeted delivery of therapeutic agents. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2016) 0.78
Intranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives. Pharmaceutics (2014) 0.78
Recent advances in live cell imaging of hepatoma cells. BMC Cell Biol (2014) 0.78
Stimuli responsive charge-switchable lipids: Capture and release of nucleic acids. Chem Phys Lipids (2016) 0.75
Nucleofection of expression vectors induces a robust interferon response and inhibition of cell proliferation. DNA Cell Biol (2013) 0.75
DNA as therapeutics; an update. Indian J Pharm Sci (2009) 0.75
Fabrication of functionalized double-lamellar multifunctional envelope-type nanodevices using a microfluidic chip with a chaotic mixer array. PLoS One (2012) 0.75
In vitro studies of liposome-mediated gene transfer into head and neck cancer cell lines. Eur Arch Otorhinolaryngol (1997) 0.75
Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. Biochemistry (1996) 4.06
Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. Bioconjug Chem (1994) 3.24
Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes. Biochim Biophys Acta (1979) 3.20
Evidence for the prion hypothesis: induction of the yeast [PSI+] factor by in vitro- converted Sup35 protein. Science (2000) 2.66
H+- and Ca2+-induced fusion and destabilization of liposomes. Biochemistry (1985) 2.44
In vitro gene delivery by degraded polyamidoamine dendrimers. Bioconjug Chem (1997) 2.28
Mechanism of oligonucleotide release from cationic liposomes. Proc Natl Acad Sci U S A (1996) 2.19
Effect of lipid composition and liposome size on toxicity and in vitro fungicidal activity of liposome-intercalated amphotericin B. Antimicrob Agents Chemother (1987) 2.14
Treatment of experimental invasive aspergillosis with novel amphotericin B/cholesterol-sulfate complexes. J Infect Dis (1989) 2.08
pH-induced destabilization of phosphatidylethanolamine-containing liposomes: role of bilayer contact. Biochemistry (1984) 2.03
The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes. Gene Ther (1997) 1.96
Intracellular oligonucleotide hybridization detected by fluorescence resonance energy transfer (FRET). Nucleic Acids Res (1994) 1.88
Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. Hum Gene Ther (1996) 1.87
Mechanism of leakage of phospholipid vesicle contents induced by the peptide GALA. Biochemistry (1990) 1.86
Cyclic amphipathic peptide-DNA complexes mediate high-efficiency transfection of adherent mammalian cells. Proc Natl Acad Sci U S A (1993) 1.65
Gene expression following direct injection of DNA into liver. Hum Gene Ther (1994) 1.59
Design, synthesis, and characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers. Biochemistry (1997) 1.56
Rapid nuclear accumulation of injected oligodeoxyribonucleotides. New Biol (1990) 1.45
Pore-forming peptides induce rapid phospholipid flip-flop in membranes. Biochemistry (1994) 1.43
Branched cationic peptides for gene delivery: role of type and number of cationic residues in formation and in vitro activity of DNA polyplexes. Hum Gene Ther (1999) 1.39
Destabilization of phosphatidylethanolamine liposomes at the hexagonal phase transition temperature. Biochemistry (1986) 1.37
Characterization of plasmid DNA transfer into mouse skeletal muscle: evaluation of uptake mechanism, expression and secretion of gene products into blood. Gene Ther (1996) 1.34
Branched polyamines cure prion-infected neuroblastoma cells. J Virol (2001) 1.32
Physicochemical characterization and purification of cationic lipoplexes. Biophys J (1999) 1.31
Steric stabilization of fusogenic liposomes by a low-pH sensitive PEG--diortho ester--lipid conjugate. Bioconjug Chem (2001) 1.28
pH-dependent bilayer destabilization by an amphipathic peptide. Biochemistry (1987) 1.27
Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells. Cancer Res (2001) 1.26
Effect of serum components on the physico-chemical properties of cationic lipid/oligonucleotide complexes and on their interactions with cells. Biochim Biophys Acta (1998) 1.24
Fusion of phosphatidylethanolamine-containing liposomes and mechanism of the L alpha-HII phase transition. Biochemistry (1986) 1.24
Intracellular distribution and mechanism of delivery of oligonucleotides mediated by cationic lipids. Pharm Res (1996) 1.23
Predicting antisense oligonucleotide inhibitory efficacy: a computational approach using histograms and thermodynamic indices. Nucleic Acids Res (1992) 1.17
Modulation of the biological activity of bacterial endotoxin by incorporation into liposomes. J Immunol (1987) 1.11
Efficiency of cytoplasmic delivery by pH-sensitive liposomes to cells in culture. Pharm Res (1990) 1.11
Antigene, ribozyme and aptamer nucleic acid drugs: progress and prospects. Pharm Res (1995) 1.00
Effect of liposome encapsulation on antigen presentation in vitro. Comparison of presentation by peritoneal macrophages and B cell tumors. J Immunol (1989) 1.00
Destabilization of phosphatidylethanolamine-containing liposomes: hexagonal phase and asymmetric membranes. Biochemistry (1987) 0.99
Acid- and calcium-induced structural changes in phosphatidylethanolamine membranes stabilized by cholesteryl hemisuccinate. Biochemistry (1985) 0.99
Association of a pH-sensitive peptide with membrane vesicles: role of amino acid sequence. Biochemistry (1990) 0.98
Enhanced transepithelial transport of peptides by conjugation to cholic acid. Bioconjug Chem (1997) 0.97
Molecular modeling of the intestinal bile acid carrier: a comparative molecular field analysis study. J Comput Aided Mol Des (1997) 0.97
On the correlation between HII phase and the contact-induced destabilization of phosphatidylethanolamine-containing membranes. Proc Natl Acad Sci U S A (1985) 0.97
Effects of replacement of the hydroxyl group of cholesterol and tocopherol on the thermotropic behavior of phospholipid membranes. Biochemistry (1985) 0.93
Cationic lipids are essential for gene delivery mediated by intravenous administration of lipoplexes. Gene Ther (1999) 0.92
Sedimentation field flow fractionation of liposomes. Science (1982) 0.92
Fluorometric determination of deoxyribonuclease I activity with PicoGreen. Anal Biochem (2000) 0.91
Antigen presentation by B cells and macrophages of cytochrome c and its antigenic fragment when conjugated to the surface of liposomes. Vaccine (1989) 0.90
Intratracheal gene delivery to the mouse airway: characterization of plasmid DNA expression and pharmacokinetics. Gene Ther (1995) 0.89
Use of the intestinal bile acid transporter for the uptake of cholic acid conjugates with HIV-1 protease inhibitory activity. Pharm Res (1997) 0.89
Surface aggregation and membrane penetration by peptides: relation to pore formation and fusion. Mol Membr Biol (1999) 0.88
Incorporation of LPS in liposomes diminishes its ability to induce tumoricidal activity and tumor necrosis factor secretion in murine macrophages. J Leukoc Biol (1988) 0.88
The use of a new radioactive-iodine labeled lipid marker to follow in vivo disposition of liposomes: comparison with an encapsulated aqueous space marker. Res Commun Chem Pathol Pharmacol (1982) 0.88
The use of aqueous space markers to determine the mechanism of interaction between phospholipid vesicles and cells. Biochim Biophys Acta (1979) 0.87
A procedure for the efficient incorporation of wild-type lipopolysaccharide into liposomes for use in immunological studies. J Immunol Methods (1988) 0.87
Orientation of the pore-forming peptide GALA in POPC vesicles determined by a BODIPY-avidin/biotin binding assay. Biophys J (1999) 0.87
Lipoplex-mediated gene delivery to the lung occurs within 60 minutes of intravenous administration. Hum Gene Ther (1999) 0.87
Effect of cholesterol and charge on pore formation in bilayer vesicles by a pH-sensitive peptide. Biophys J (1996) 0.87
A simple in vitro model to study the release kinetics of liposome encapsulated material. J Control Release (1998) 0.87
pH-dependent fusion of phosphatidylcholine small vesicles. Induction by a synthetic amphipathic peptide. J Biol Chem (1988) 0.86
Synthesis and characterization of a trigalactosylated bisacridine compound to target DNA to hepatocytes. Bioconjug Chem (1993) 0.86
Iontophoretic delivery of a series of tripeptides across the skin in vitro. Pharm Res (1991) 0.85
Effect of phospholipid composition on an amphipathic peptide-mediated pore formation in bilayer vesicles. Biophys J (2000) 0.85
Photoaffinity labeling of three renal cyclic 3',5'-adenosine monophosphate-binding proteins. Biochim Biophys Acta (1979) 0.85
Robust and prolonged gene expression from injectable polymeric implants. Gene Ther (2002) 0.85
Synthesis and characterization of long chain alkyl acyl carnitine esters. Potentially biodegradable cationic lipids for use in gene delivery. J Med Chem (1998) 0.85
Mechanism of lipoplex gene delivery in mouse lung: binding and internalization of fluorescent lipid and DNA components. Gene Ther (2001) 0.85
Gene delivery and expression in human retinal pigment epithelial cells: effects of synthetic carriers, serum, extracellular matrix and viral promoters. J Drug Target (2000) 0.84
Effects of complement depletion on the pharmacokinetics and gene delivery mediated by cationic lipid-DNA complexes. Hum Gene Ther (1998) 0.84
Cholesterol phosphate derivatives: synthesis and incorporation into a phosphatase and calcium-sensitive triggered release liposome. Bioconjug Chem (1999) 0.84
Simple mixing device to reproducibly prepare cationic lipid-DNA complexes (lipoplexes). Biotechniques (1999) 0.84
An in vitro messenger RNA binding assay as a tool for identifying hybridization-competent antisense oligonucleotides. Antisense Nucleic Acid Drug Dev (1996) 0.83
Optical measurement of aqueous potassium concentration by a hydrophobic indicator in lipid vesicles. Biophys Chem (1989) 0.82
Efficient adventitial gene delivery to rabbit carotid artery with cationic polymer-plasmid complexes. Gene Ther (1999) 0.81
Prolonged systemic delivery of peptide drugs by long-circulating liposomes: illustration with vasopressin in the Brattleboro rat. Pharm Res (1992) 0.80
Phage display selection of a peptide DNase II inhibitor that enhances gene delivery. J Gene Med (2001) 0.80
Fibre optic sensor for the detection of potassium using fluorescence energy transfer. Analyst (1990) 0.79
Many are probed, but few are chosen. Nat Biotechnol (1997) 0.78
Lectins as a probe for carbohydrate residues in non-neoplastic urothelium of human urinary bladder. J Urol (1982) 0.78
Lecithin:cholesterol acyltransferase activation by synthetic amphipathic peptides. Proteins (1988) 0.78
Amino acid side-chain contributions to free energy of transfer of tripeptides from water to octanol. Pharm Res (1992) 0.78
Controlled template-assisted assembly of plasmid DNA into nanometric particles with high DNA concentration. Bioconjug Chem (2000) 0.77
Uptake of liposome-encapsulated agents. Methods Enzymol (1987) 0.77
Iontophoresis of bases, nucleosides, and nucleotides. Pharm Res (1996) 0.76
Alteration of liposome disposition in vivo by bilayer situated carbohydrates. Biochem Biophys Res Commun (1983) 0.75
Single-stranded phosphodiester and phosphorothioate oligonucleotides bind actinomycin D and interfere with tumor necrosis factor-induced lysis in the L929 cytotoxicity assay. Antisense Res Dev (1993) 0.75
Adenosine 3' :5' -monophosphate-dependnet phosphorylations of renal subcellular fractions. Differences between cortical and medullary membrane preparations. J Biol Chem (1978) 0.75
Structural studies of the monolayers and bilayers formed by a novel cholesterol-phospholipid chimera. Langmuir (2011) 0.75